We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
-0.25%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$219M
AUM Growth
-$6.3M
(-2.8%)
Cap. Flow
+$7.95M
Cap. Flow
% of AUM
3.64%
Top 10 Holdings %
Top 10 Hldgs %
11.93%
Holding
763
New
327
Increased
77
Reduced
54
Closed
297
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$2.61M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.35M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$2.15M |
| 4 |
Teck Resources
TECK
|
+$2.12M |
| 5 |
BlackRock Health Sciences Trust II
BMEZ
|
+$2.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$3.72M |
| 2 |
Cintas
CTAS
|
+$3.03M |
| 3 |
BCOV
Brightcove, Inc.
BCOV
|
+$2.87M |
| 4 |
Verizon
VZ
|
+$2.3M |
| 5 |
Veeva Systems
VEEV
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.88% |
| 2 | Financials | 13.01% |
| 3 | Technology | 12.25% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Industrials | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Puma Biotechnology
PBYI
$442M
| $52.2K | 0.02% |
17,647
-5,837
| -25% | -$18.3K |
|
452
Gray Television
GTN
$512M
| $51.4K | 0.02% |
11,905
-80,016
| -87% | -$315K |
|
453
NovaGold Resources
NG
$3.35B
| $49.4K | 0.02% |
+16,920
| New | +$54.4K |
|
454
Magnachip Semiconductor
MX
$134M
| $49.2K | 0.02% |
+14,343
| New | +$60.4K |
|
455
Clean Energy Fuels
CLNE
$355M
| $45.4K | 0.02% |
+29,286
| New | +$74.4K |
|
456
TMC The Metals Company
TMC
$1.92B
| $43.9K | 0.02% |
+25,519
| New | +$42.9K |
|
457
Butterfly Network
BFLY
$2.58B
| $39.1K | 0.02% |
17,130
-8,111
| -32% | -$29K |
|
458
Clarus
CLAR
$145M
| $38.5K | 0.02% |
+10,277
| New | +$46.1K |
|
|
SGRP
459
DELISTED
SPAR Group
SGRP
| $36.3K | 0.02% |
27,500
-123,251
| -82% | -$211K |
|
460
Perspective Therapeutics
CATX
$342M
| $31.5K | 0.01% |
14,805
+4,730
| +47% | +$14.2K |
|
461
Community Health Systems
CYH
$415M
| $28.3K | 0.01% |
+10,476
| New | +$32.6K |
|
|
TRUE
462
DELISTED
TrueCar
TRUE
| $24.5K | 0.01% |
+15,485
| New | +$43K |
|
|
ASM
463
Avino Silver & Gold Mines
ASM
$1.28B
| $22.3K | 0.01% |
12,098
-14,224
| -54% | -$19.4K |
|
464
Cabaletta Bio
CABA
$457M
| $21.3K | 0.01% |
+15,405
| New | +$32.8K |
|
465
Sutro Biopharma
STRO
$423M
| $14.9K | 0.01% |
+2,285
| New | +$36K |
|
466
Nektar Therapeutics
NKTR
$2.53B
| $11.6K | 0.01% |
+1,135
| New | +$14.8K |
|
467
Abeona Therapeutics
ABEO
$425M
| – | – |
-21,121
| Closed | -$118K |
|
468
Acadia Pharmaceuticals
ACAD
$5.06B
| – | – |
-11,925
| Closed | -$219K |
|
469
Archer Aviation
ACHR
$4.78B
| – | – |
-20,650
| Closed | -$201K |
|
470
Adobe
ADBE
$109B
| – | – |
-523
| Closed | -$233K |
|
471
Archer Daniels Midland
ADM
$38.8B
| – | – |
-8,697
| Closed | -$439K |
|
472
ADMA Biologics
ADMA
$2.18B
| – | – |
-13,420
| Closed | -$230K |
|
473
AudioEye
AEYE
$73.2M
| – | – |
-10,704
| Closed | -$163K |
|
474
Assured Guaranty
AGO
$3.36B
| – | – |
-12,101
| Closed | -$1.09M |
|
|
AISP
475
Airship AI Holdings
AISP
$69.9M
| – | – |
-18,794
| Closed | -$118K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Oxford Asset Management held 763 positions worth $219M, down 2.8% from $225M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Oxford Asset Management deployed $7.95M of net new capital in Q1 2025, opening 327 new positions and adding to 77 existing holdings. Its largest new stake was Oracle: 16,001 shares worth $2.24M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Cintas, an estimated $3.03M trimmed.
- Oxford Asset Management's largest Q1 2025 buy was Oracle: 16,001 shares worth $2.24M.
- Oxford Asset Management added most to NEVRO CORP. in Q1 2025, an estimated $2.05M increase.
- Oxford Asset Management's biggest Q1 2025 reduction was Cintas, cutting an estimated $3.03M.
- Oxford Asset Management fully exited Avid Bioservices, Inc. Common Stock in Q1 2025, selling an estimated $3.72M.
- Oxford Asset Management's ten largest holdings make up 12% of its $219M portfolio in Q1 2025.
- Oxford Asset Management opened 327 new positions and closed 297 in Q1 2025.
- Oxford Asset Management's portfolio value fell 2.8% quarter-over-quarter to $219M.
Based on Oxford Asset Management's 13F filing for Q1 2025, filed 15 May 2025.